1. Home
  2. MUX vs AMLX Comparison

MUX vs AMLX Comparison

Compare MUX & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

HOLD

Current Price

$26.21

Market Cap

1.6B

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$14.44

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUX
AMLX
Founded
1979
2014
Country
Canada
United States
Employees
1432
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MUX
AMLX
Price
$26.21
$14.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
9
Target Price
$26.63
$21.56
AVG Volume (30 Days)
951.9K
993.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.46
EPS
N/A
N/A
Revenue
N/A
$380,786,000.00
Revenue This Year
$37.86
N/A
Revenue Next Year
$31.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1612.94
52 Week Low
$7.15
$4.64
52 Week High
$29.70
$18.61

Technical Indicators

Market Signals
Indicator
MUX
AMLX
Relative Strength Index (RSI) 63.95 36.63
Support Level $22.96 $13.02
Resistance Level $26.27 $15.37
Average True Range (ATR) 1.34 0.86
MACD 0.32 -0.34
Stochastic Oscillator 93.77 4.36

Price Performance

Historical Comparison
MUX
AMLX

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: